What’s new in sleep medicine (2024–2025): therapies, diagnostics, and prodromal biomarkers

Below is a clinician-focused synthesis of the most consequential recent developments in sleep medicine, with primary literature for follow-up. 1) Pharmacotherapy for obstructive sleep apnoea (OSA) GLP-1/GIP agonist for OSA:…

Continue ReadingWhat’s new in sleep medicine (2024–2025): therapies, diagnostics, and prodromal biomarkers